Media Relations News Releases Year: - Any -201820172016 Items per page 102550 Sep 15, 2016 Summary ToggleNovartis presents new positive data at EHMTIC showing AMG 334 significantly reduces monthly migraine days in chronic migraine Sep 9, 2016 Summary ToggleNew Novartis point of care Niji™ System may provide earlier diagnosis of severe allergic asthma and faster treatment decisions Jun 29, 2016 Summary ToggleLargest global psoriasis survey shows 84% of people face discrimination and humiliation because of their skin Jun 10, 2016 Summary ToggleNovartis drug Afinitor® receives EU approval to treat certain types of advanced gastrointestinal (GI) and lung neuroendocrine tumors (NET) Jun 8, 2016 Summary ToggleNovartis presents new scientific evidence for Cosentyx in ankylosing spondylitis and psoriatic arthritis patients at EULAR 2016 Jun 4, 2016 Summary ToggleNovartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna® Jun 1, 2016 Summary ToggleExpanding access to affordable treatments against chronic diseases – Novartis Access hosts second stakeholder dialogue May 17, 2016 Summary ToggleNovartis Foundation and partners launch innovative hypertension program in Vietnam May 15, 2016 Summary ToggleMajor study published in NEJM confirms Novartis’ Ultibro® Breezhaler® superiority over Seretide® in preventing COPD exacerbations Apr 27, 2016 Summary ToggleNovartis receives three FDA Breakthrough Therapy Designations for Ilaris to treat rare types of Periodic Fever Syndromes Pagination First page First Previous page Previous … Page 6 Page 7 Current page 8 Page 9 Next page Next Last page Last
